Covalon Technologies Ltd. (OTCMKTS:CVALF) Short Interest Up 650.0% in October

Covalon Technologies Ltd. (OTCMKTS:CVALF) saw a significant increase in short interest in October. As of October 31st, there was short interest totalling 12,000 shares, an increase of 650.0% from the October 15th total of 1,600 shares. Based on an average daily volume of 26,500 shares, the days-to-cover ratio is presently 0.5 days.

Covalon Technologies Trading Down 4.6 %

Shares of OTCMKTS:CVALF traded down $0.12 during trading on Thursday, hitting $2.56. 18,642 shares of the company’s stock traded hands, compared to its average volume of 15,062. The company has a market cap of $70.02 million, a price-to-earnings ratio of -85.16 and a beta of -0.34. The company has a 50-day moving average price of $2.40 and a 200-day moving average price of $1.80. Covalon Technologies has a 52 week low of $0.73 and a 52 week high of $3.08.

Covalon Technologies (OTCMKTS:CVALF) last released its quarterly earnings data on Wednesday, August 21st. The company reported $0.04 earnings per share (EPS) for the quarter. Covalon Technologies had a negative return on equity of 4.40% and a negative net margin of 2.94%. The company had revenue of $6.74 million during the quarter.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.